These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20237223)

  • 1. Polymorphisms in the CPB2 gene are maintained by balancing selection and result in haplotype-preferential splicing of exon 7.
    Cagliani R; Fumagalli M; Riva S; Pozzoli U; Fracassetti M; Bresolin N; Comi GP; Sironi M
    Mol Biol Evol; 2010 Aug; 27(8):1945-54. PubMed ID: 20237223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mRNA encoding TAFI is alternatively spliced in different cell types and produces intracellular forms of the protein lacking TAFIa activity.
    Lin JH; Novakovic D; Rizzo CM; Zagorac B; Garand M; Filipieva A; Koschinsky ML; Boffa MB
    Thromb Haemost; 2013 Jun; 109(6):1033-44. PubMed ID: 23595589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability in the ACE gene region surrounding the Alu I/D polymorphism is maintained by balancing selection in human populations.
    Cagliani R; Fumagalli M; Riva S; Pozzoli U; Comi GP; Bresolin N; Sironi M
    Pharmacogenet Genomics; 2010 Feb; 20(2):131-4. PubMed ID: 20038859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the association of thrombin activatable fibrinolysis inhibitor and the Thr325Ile and Thr147Ala polymorphisms of its encoding gene CPB2 in patients with coronary heart disease].
    Xu CW; Wang LL; Wu XB; Zhao JJ; Du YM; Jiang CY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):438-42. PubMed ID: 18683146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter.
    Garand M; Bastajian N; Nesheim ME; Boffa MB; Koschinsky ML
    Br J Haematol; 2007 Jul; 138(2):231-44. PubMed ID: 17593031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
    de Bruijne EL; Darwish Murad S; de Maat MP; Tanck MW; Haagsma EB; van Hoek B; Rosendaal FR; Janssen HL; Leebeek FW;
    Thromb Haemost; 2007 Feb; 97(2):181-5. PubMed ID: 17264944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).
    Boffa MB; Reid TS; Joo E; Nesheim ME; Koschinsky ML
    Biochemistry; 1999 May; 38(20):6547-58. PubMed ID: 10350473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition.
    Takada K; Seike T; Sasaki T; Masuda Y; Ito A; Ishii H
    Thromb Haemost; 2013 Jun; 109(6):1060-9. PubMed ID: 23572161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
    Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide analysis of transcript isoform variation in humans.
    Kwan T; Benovoy D; Dias C; Gurd S; Provencher C; Beaulieu P; Hudson TJ; Sladek R; Majewski J
    Nat Genet; 2008 Feb; 40(2):225-31. PubMed ID: 18193047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
    Ladenvall C; Gils A; Jood K; Blomstrand C; Declerck PJ; Jern C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):955-62. PubMed ID: 17272741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.
    Rittore C; Sanchez E; Soler S; Barat-Houari M; Albers M; Obici L; McDermott MF; Touitou I; Grandemange S
    Ann Rheum Dis; 2014 Jan; 73(1):290-7. PubMed ID: 23505244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex variation at class II DQA locus in the brown hare (Lepus europaeus).
    Koutsogiannouli EA; Moutou KA; Sarafidou T; Stamatis C; Spyrou V; Mamuris Z
    Mol Ecol; 2009 Nov; 18(22):4631-49. PubMed ID: 19845856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the Thr325Ile polymorphism of the thrombin-activatable fibrinolysis inhibitor and stroke in the Ludwigshafen Risk and Cardiovascular Health Study.
    Kozian DH; Lorenz M; März W; Cousin E; Mace S; Deleuze JF
    Thromb Haemost; 2010 May; 103(5):976-83. PubMed ID: 20216989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.
    Boffa MB; Maret D; Hamill JD; Bastajian N; Crainich P; Jenny NS; Tang Z; Macy EM; Tracy RP; Franco RF; Nesheim ME; Koschinsky ML
    Blood; 2008 Jan; 111(1):183-9. PubMed ID: 17855631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
    Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
    Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
    Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
    Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
    Martini CH; Brandts A; de Bruijne EL; van Hylckama Vlieg A; Leebeek FW; Lisman T; Rosendaal FR
    Br J Haematol; 2006 Jul; 134(1):92-4. PubMed ID: 16803573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.